logo
Select company
Select metric
$ -4.96MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
35
Sector
39
Industry
43
History
23
$ 3.56Close
$ 2.35 - $ 6.36 52-Week Range
Ticker Information

Ticker

OBIO

Company Name

ORCHESTRA BIOMED HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ORCHESTRA BIOMED HOLDINGS INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

OBIO - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -4.96M
3/31/2025$ -4.98M
12/31/2024$ -8.3M
9/30/2024$ 6.53M
6/30/2024$ 7.3M
3/31/2024$ 4.63M
12/31/2023$ 10.78M
9/30/2023$ -77.92M
9/30/2022$ -1.05M
6/30/2022$ -604.6K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ORCHESTRA BIOMED HOLDINGS INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 2.03M.
  • Over the past 5 years, ORCHESTRA BIOMED HOLDINGS INC's average CF - Chg. Cash has been $ -4.7M.
  • The median CF - Chg. Cash for ORCHESTRA BIOMED HOLDINGS INC during this period was $ -401.96K
  • ORCHESTRA BIOMED HOLDINGS INC reached its highest CF - Chg. Cash over the past 5 years at $ 10.78M.
  • The lowest CF - Chg. Cash recorded by ORCHESTRA BIOMED HOLDINGS INC in the same timeframe $ -77.92M

ORCHESTRA BIOMED HOLDINGS INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
CNTB : CONNECT BIOPHARMA HOLDINGS LTD $ -69.29MPYXS : PYXIS ONCOLOGY INC $ -14.34MNTRB : NUTRIBAND INC $ 235.13KACOG : ALPHA COGNITION INC $ 38.27MORMP : ORAMED PHARMACEUTICALS INC $ -68.96MSTTK : SHATTUCK LABS INC $ -10.23MALGS : ALIGOS THERAPEUTICS INC $ -26.38MOTLK : OUTLOOK THERAPEUTICS INC $ -23.12MCAMP : CAMP4 THERAPEUTICS CORP $ 26.45MARMP : ARMATA PHARMACEUTICALS INC $ -22.17M

Similar metrics to CF - Chg. Cash:

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

OBIO - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -77.92M

Minimum

Sep 30, 2023

$ 10.78M

Maximum

Dec 31, 2023

$ -4.7M

Average

$ -401.96K

Median

CF - Chg. Cash Benchmark Analysis

 The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.12M with a standard deviation of $ 45.01M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -137M
max$ 137.58M
average$ 1.12M
median$ 104K
std$ 45.01M